First attempt at genome editing in U.S. patients produces sobering results

First attempt at genome editing in U.S. patients produces sobering results

STAT Plus: First attempt at genome editing in U.S. patients produces disappointing — and sobering — results

By ADAM FEUERSTEIN

ALEX HOGAN/STAT

A landmark attempt by Sangamo Therapeutics to use groundbreaking technology to repair disease-causing DNA has fallen short of high expectations.

READ MORE